Plasma Kallistatin Levels in Patients With Severe Community-Acquired Pneumonia

Critical Care - United Kingdom
doi 10.1186/cc12507
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Plasma D-Dimer Levels Correlate With Outcomes in Patients With Community-Acquired Pneumonia

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Severe Sepsis in Community-Acquired Pneumonia

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2006English

Adrenal Function in Patients With Community-Acquired Pneumonia

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2008English

Hydrocortisone Infusion for Severe Community-Acquired Pneumonia

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2005English

Low-Dose Corticosteroid Use and Mortality in Severe Community-Acquired Pneumonia Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Prognostic Value of Proadrenomedullin in Severe Sepsis and Septic Shock Patients With Community-Acquired Pneumonia

Critical Care
Critical CareIntensive Care Medicine
2011English

Pre-Analytic Factors and Initial Biomarker Levels in Community-Acquired Pneumonia Patients

BMC Anesthesiology
AnesthesiologyPain Medicine
2014English

One-Year Mortality in Patients With Community-Acquired Pneumonia

Journal of Respiratory Infections
2017English

Screening for Humoral Immunodeficiency in Patients With Community-Acquired Pneumonia

Journal of Hospital Medicine
Internal MedicineCare PlanningHealth PolicyFundamentalsSkillsLeadershipManagementDiagnosisMedicineAssessment
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy